Please join us on Wednesday 26th January from 12:00- 13:00 at the CRI Interface Section External Seminars.

We will have an exciting talk from Dr Tamir Rashid on Human stem cells for modelling alpha1 antitrypsin deficiency’.

Dr Rashid is a Clinical Reader and Consultant Hepatologist. After graduating in medicine from Imperial College School of Medicine at St Mary’s, he completed his clinician-scientist training at the University of Cambridge (as a Wellcome Trust Clinical PhD fellow then NIHR Clinical Lecturer) under the supervision of Professors David Lomas and Ludovic Vallier. He was then awarded an MRC Clinician Scientist Fellowship and undertook post-doctoral studies at Stanford (USA) under the mentorship of Professors Hiromitsu Nakauchi and Jeffrey Glenn before returning to King’s College London to establish his first laboratory under the directorship of Professor Fiona Watt. In 2020, Dr Rashid moved back to Imperial and set up his lab on the 10th floor of the Commonwealth building along with the BRC-Imperial Centre for iPS/Organoid disease modelling.

The research programme of the Rashid lab focuses on the use of human stem cells for modelling and treating genetic liver diseases. His specific objectives are to generate deeper mechanistic understanding, identify new molecular targets and produce cell & gene based regenerative medicine approaches. These translational ambitions are closely linked to his clinical work in which he runs the NW Thames genetic liver disease service, several clinical trials and the British Liver Association’s Alpha-1 Antitrypsin specialist interest group.

Over the last 15 years, the impact of Dr Rashid’s work has been recognised through the receipt of numerous international (the American Liver Association Fellow’s Prize) and national (Academy of Medical Sciences UK Young Investigator & British Liver Association Young Investigator) prizes and the creation of two biotech start-ups.

The event will be on Microsoft Teams.